Related Experiment Video
Updated: May 11, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Mutagenic activation reduces carcinogenic activity of ortho-aminoazotoluene for mouse liver
L P Ovchinnikova1, L A Bogdanova, V I Kaledin
1Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.
Abstract:
Pentachlorophenol (aromatic amine and azo stain metabolic stimulation inhibitor) reduced the hepatocarcinogenic activity of 4-aminoazobenzene and reduced that of ortho-aminoazotoluene in suckling mice. Both 4-aminoazobenzene and ortho-aminoazotoluene exhibited mutagenic activity in Ames' test in vitro on S. typhimurium TA 98 strain with activation with liver enzymes; this mutagenic activity was similarly suppressed by adding pentachlorophenol into activation medium. Induction of xenobiotic metabolism enzymes, stimulating the mutagenic activity of ortho-aminoazotoluene, suppressed its carcinogenic effect on mouse liver. Hence, ortho-aminotoluene (the initial compound), but not its mutagenic metabolites, was the direct active hepatocarcinogen for mice.
Insights
Pentachlorophenol inhibited the liver cancer activity of aromatic amines like 4-aminoazobenzene and ortho-aminoazotoluene in mice. This suggests the parent compound, not its metabolites, is the primary liver carcinogen.
Area of Science:
- Toxicology
- Hepatocarcinogenesis
- Metabolic enzyme induction
Background:
- Aromatic amines are known carcinogens, with their activity often modulated by metabolic processes.
- Pentachlorophenol is recognized as an inhibitor of metabolic enzyme stimulation.
Purpose of the Study:
- To investigate the effect of pentachlorophenol on the hepatocarcinogenic activity of 4-aminoazobenzene and ortho-aminoazotoluene.
- To elucidate the role of metabolic activation in the carcinogenicity of ortho-aminoazotoluene.
Main Methods:
- Administration of 4-aminoazobenzene and ortho-aminoazotoluene to suckling mice.
- In vitro mutagenicity testing using Ames' test (S. typhimurium TA 98 strain) with liver enzyme activation.
- Assessment of pentachlorophenol's effect on carcinogenicity and mutagenicity.
Main Results:
- Pentachlorophenol significantly reduced the liver tumor-inducing potential of both 4-aminoazobenzene and ortho-aminoazotoluene.
- Pentachlorophenol suppressed the mutagenic activity of these compounds in the Ames' test.
- Enzyme induction that enhanced ortho-aminoazotoluene's mutagenicity concurrently reduced its carcinogenic effect.
Conclusions:
- The parent compound, ortho-aminotoluene, is identified as the direct hepatocarcinogen in mice, rather than its mutagenic metabolites.
- Pentachlorophenol acts as an inhibitor, reducing the carcinogenic and mutagenic potential of these aromatic amines.
Related Concept Videos
Mutagenicity and Carcinogenicity
Bioactivation and Tissue Toxicity
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Spontaneous and Induced Mutations
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
